C21 · Pharmaceuticals · China
Innovative drug out-licensing deal value (half year)
China: 100 billion USD in January–June 2026.
- 100 billion USD Latest · China · January–June 2026
- Irregular Release cadence
- 3 Records · 1 region · 2026
Verified 27 Sep 2026 · 3 publishers · Next period July–December 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
Innovative drug out-licensing deal value (half year)
China, January–June 2026
Every record
3 records · 1 region · 2026. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| China 3 records | |||
| January–June 2026 | 100 billion USD | State Council · 30 Jun 2026 | |
| January–June 2026 | 100 billion USD | MOFCOM · 30 Jun 2026 | |
| January–June 2026 | 110 billion USD | NHSA · 30 Jun 2026 | estimate |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: State Council, MOFCOM, NHSA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (State Council, MOFCOM, NHSA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Total monetary value of out-licensing agreements signed for innovative pharmaceutical products.
- Measure
- One slice of Out-licensing deal value ( form: level, segment: innovative ) . Total monetary value of out-licensing agreements signed for pharmaceutical assets. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 3 documents
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 上半年我国创新药对外技术授权交易额创新高 | MOFCOM | — | 1 |
| 我国上半年创新药对外授权交易额超千亿美元 | NHSA | — | 1 |
| China to expand health insurance coverage for innovative drugs | State Council | — | 1 |
Other slices of out-licensing deal value
- Innovative drug out-licensing deal value 5 innovative
- Innovative drug licensing-out upfront payment value 1 cumulative · upfront payment · innovative
Frequently asked questions
What is the latest innovative drug out-licensing deal value (half year)?
China: 100 billion USD in January–June 2026.
Where does this data come from?
From 3 documents published by State Council, MOFCOM, NHSA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Innovative drug out-licensing deal value (half year) [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/innovative-drug-out-licensing-deal-value-half-year
"Innovative drug out-licensing deal value (half year)." StatOrigin, 2026, https://statorigin.org/indicators/innovative-drug-out-licensing-deal-value-half-year. Accessed 28 Oct. 2026.
StatOrigin. "Innovative drug out-licensing deal value (half year)." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/innovative-drug-out-licensing-deal-value-half-year.
@misc{statorigin_innovative_drug_out_licensing_deal_value_half_year_2026, title = {Innovative drug out-licensing deal value (half year)}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/innovative-drug-out-licensing-deal-value-half-year}, note = {Data set. Accessed 2026-10-28} }